Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation
. 2025 May 29:20:751-762.
doi: 10.2147/CIA.S503980. eCollection 2025.

Higher Clinical Frailty Scale is Associated with Higher Visit-to-Visit Glycated Hemoglobin (HbA1c) Variability in Patients with Type 2 Diabetes Mellitus: A Propensity Score-Matched Study

Affiliations

Higher Clinical Frailty Scale is Associated with Higher Visit-to-Visit Glycated Hemoglobin (HbA1c) Variability in Patients with Type 2 Diabetes Mellitus: A Propensity Score-Matched Study

Yuping Zhang et al. Clin Interv Aging. .

Abstract

Objective: Patients with type 2 diabetes mellitus (T2DM) have high risk of frailty. The clinical frailty scale (CFS) has been used to evaluate clinical frailty. To evaluate the association between CFS and visit-to-visit glycated hemoglobin (HbA1C) variability in T2DM patients.

Methods: Patients who were hospitalized with T2DM and received at least three HbA1C tests after discharging from endocrinology department and general practice department during 12-month follow-up were retrospectively enrolled. The patients were divided into the low-HbA1C variability group and the high-HbA1C variability group according to the results of the HbA1C variability score (HVS). The baseline clinical information, including CFS during hospitalization, was collected and compared between the two groups. We performed a propensity score match (PSM) to eliminate the influences of other confounding factors.

Results: A total of 370 patients were included in this study. Most baseline demographic, clinical parameters and metabolic parameters were comparable between the two groups except age, baseline HbA1C, albumin, and comorbidities including hypertension and dyslipidemia between the two groups before PSM. All of the relative parameters were comparable after a 1:1 PSM. Uni-variable and multi-variable logistic analysis revealed that higher CFS was associated with higher HbA1C variability and receiver operating characteristic curve showed that CFS had good predictive value in HVS.

Conclusion: Higher CFS was associated with higher visit-to-visit HbA1C variability.

Keywords: HbA1C variability score; clinical frailty scale; propensity score match; type 2 diabetes mellitus.

PubMed Disclaimer

Conflict of interest statement

The authors report no conflicts of interest in this work.

Figures

Figure 1
Figure 1
Study flow chart.
Figure 2
Figure 2
The process of propensity score-matched analysis.
Figure 3
Figure 3
Results of the receiver operating characteristic curve.

Similar articles

References

    1. Tinajero MG, Malik VS. An update on the epidemiology of type 2 diabetes: a global perspective. Endocrinol Metab Clin North Am. 2021;50(3):337–355. doi:10.1016/j.ecl.2021.05.013 - DOI - PubMed
    1. Chan JCN, Yang A, Chu N, et al. Current type 2 diabetes guidelines: individualized treatment and how to make the most of metformin. Diabetes Obes Metab. 2024;26(Suppl 3):55–74. doi:10.1111/dom.15700 - DOI - PubMed
    1. Jia W, Weng J, Zhu D, et al. Standards of medical care for type 2 diabetes in China 2019. Diabetes Metab Res Rev. 2019;35(6):e3158. doi:10.1002/dmrr.3158 - DOI - PubMed
    1. Li F, Zhang L, Shen Y, et al. Higher glucose fluctuation is associated with a higher risk of cardiovascular disease: insights from pooled results among patients with diabetes. J Diabetes. 2023;15(5):368–381. doi:10.1111/1753-0407.13386 - DOI - PMC - PubMed
    1. Fang Q, Shi J, Zhang J, et al. Visit-to-visit HbA1c variability is associated with aortic stiffness progression in participants with type 2 diabetes. Cardiovasc Diabetol. 2023;22(1):167. doi:10.1186/s12933-023-01884-7 - DOI - PMC - PubMed

Substances

LinkOut - more resources